Get to know Innovative Diagnostics Laboratory
Innovative Diagnostics Laboratory (“IDL”) is a national clinical reference lab specializing in personalized blood-based testing to find, understand, and treat cancer.
Approximately 40% of the US population will be diagnosed with cancer in their lifetime. IDL provides physicians and their patients at risk of cancer with easy to understand personalized clinical intelligence to improve shared decision making and health outcomes. Today, advanced cancer tests are primarily being marketed to medical specialists including pathologists and oncologists after the patient has been diagnosed with cancer. Often these tests are only available at the leading medical academic medical centers. IDL believes optimal care for those at increased risk for cancer starts with the primary care physician and their patient prior to cancer diagnosis and regardless of where they live.
ColonSentry®: an easy test for an early warning
The key to beating colorectal cancer is knowing your risks.
Colorectal cancer is the second biggest cancer killer in the United States among cancers that affect both men and women, claiming more than 50,000 lives per year. 1,2
CRC is a highly preventable cancer when caught early,3 yet screening lags behind other cancers.4
With early detection and appropriate treatment, this is a cancer battle you can win.
EarlyCDT®-Lung is a simple blood test that aids physicians in risk assessment and the early detection of lung cancer in high-risk, asymptomatic patients. Elevation of any one of the 7 autoantibodies above a predetermined cut-off suggests that a tumor might be present.1
The Prostate Health Index (PHI) ®
This test is 3 times better than standard PSA testing for detecting prostate cancer.
This score provides a personalized assessment of prostate cancer risk to help you and your doctor determine with more confidence than ever before whether biopsy is the right choice for you.
For more information on these tests please visit http://www.myinnovativelab.com/